Mesoblast Management

Management criteria checks 3/4

Mesoblast's CEO is Silviu Itescu, appointed in Jan 2011, has a tenure of 13.17 years. total yearly compensation is $1.11M, comprised of 60.6% salary and 39.4% bonuses, including company stock and options. directly owns 6.94% of the company’s shares, worth A$39.19M. The average tenure of the management team and the board of directors is 4.4 years and 5.8 years respectively.

Key information

Silviu Itescu

Chief executive officer

US$1.1m

Total compensation

CEO salary percentage60.6%
CEO tenure13.2yrs
CEO ownership6.9%
Management average tenure4.4yrs
Board average tenure5.8yrs

Recent management updates

Recent updates

Does Mesoblast (ASX:MSB) Have A Healthy Balance Sheet?

Jun 21
Does Mesoblast (ASX:MSB) Have A Healthy Balance Sheet?

Does Mesoblast (ASX:MSB) Have A Healthy Balance Sheet?

Jun 06
Does Mesoblast (ASX:MSB) Have A Healthy Balance Sheet?

Auditors Are Concerned About Mesoblast (ASX:MSB)

Sep 04
Auditors Are Concerned About Mesoblast (ASX:MSB)

Analysts Are More Bearish On Mesoblast Limited (ASX:MSB) Than They Used To Be

Mar 04
Analysts Are More Bearish On Mesoblast Limited (ASX:MSB) Than They Used To Be

Should Mesoblast (ASX:MSB) Be Disappointed With Their 54% Profit?

Feb 23
Should Mesoblast (ASX:MSB) Be Disappointed With Their 54% Profit?

CEO Compensation Analysis

How has Silviu Itescu's remuneration changed compared to Mesoblast's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$73m

Sep 30 2023n/an/a

-US$81m

Jun 30 2023US$1mUS$673k

-US$82m

Mar 31 2023n/an/a

-US$81m

Dec 31 2022n/an/a

-US$84m

Sep 30 2022n/an/a

-US$86m

Jun 30 2022US$1mUS$697k

-US$91m

Mar 31 2022n/an/a

-US$92m

Dec 31 2021n/an/a

-US$97m

Sep 30 2021n/an/a

-US$97m

Jun 30 2021US$2mUS$757k

-US$99m

Mar 31 2021n/an/a

-US$109m

Dec 31 2020n/an/a

-US$98m

Sep 30 2020n/an/a

-US$97m

Jun 30 2020US$2mUS$697k

-US$78m

Mar 31 2020n/an/a

-US$66m

Dec 31 2019n/an/a

-US$76m

Sep 30 2019n/an/a

-US$76m

Jun 30 2019US$1mUS$709k

-US$90m

Mar 31 2019n/an/a

-US$90m

Dec 31 2018n/an/a

-US$86m

Sep 30 2018n/an/a

-US$48m

Jun 30 2018US$2mUS$748k

-US$35m

Mar 31 2018n/an/a

-US$42m

Dec 31 2017n/an/a

-US$30m

Sep 30 2017n/an/a

-US$64m

Jun 30 2017US$1mUS$776k

-US$77m

Compensation vs Market: Silviu's total compensation ($USD1.11M) is above average for companies of similar size in the Australian market ($USD778.29K).

Compensation vs Earnings: Silviu's compensation has been consistent with company performance over the past year.


CEO

Silviu Itescu (66 yo)

13.2yrs

Tenure

US$1,109,634

Compensation

Prof. Silviu Itescu, MBBS (Hons), FRACP, FACP, FACRA, FTSE has been the Chief Executive Officer and Managing Director of Mesoblast Limited since 2011. Prof. Itescu is the Chief Executive Officer at Mesobla...


Leadership Team

NamePositionTenureCompensationOwnership
Silviu Itescu
Founder13.2yrsUS$1.11m6.94%
$ 39.2m
Eric Rose
Chief Medical Officer & Executive Director2.1yrsUS$1.02mno data
Andrew Chaponnel
Interim Chief Finance Officer2.6yrsno datano data
Peter Howard
General Counsel & Corporate Executive12.7yrsno datano data
Roger Brown
Head of Spinal Orthopedic Disorders8.4yrsno datano data
Michael Schuster
Head of Pharma Partneringno datano datano data
Geraldine Storton
Head of Regulatory Affairs & Quality Managementno datano datano data
Justin Horst
Head of Manufacturingno datano datano data
Niva Sivakumar
Joint Company Secretary4.4yrsno datano data
Paul Hughes
Joint Company Secretary1.9yrsno datano data
Kenneth Borow
Executiveno datano datano data

4.4yrs

Average Tenure

66yo

Average Age

Experienced Management: MSB's management team is considered experienced (4.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Silviu Itescu
Founder16.8yrsUS$1.11m6.94%
$ 39.2m
Eric Rose
Chief Medical Officer & Executive Director10.9yrsUS$1.02mno data
Philip Facchina
Independent Non-Executive Director3yrsUS$135.62k0.011%
$ 61.2k
Joseph Swedish
Independent Non-Executive Chairman5.8yrsUS$247.95k0.040%
$ 228.0k
William A. Burns
Independent Non-Executive Vice Chairman10yrsUS$132.70k0.0093%
$ 52.7k
Henry Krum
Member of Scientific Advisory Boardno datano datano data
Joseph Lane
Member of Scientific Advisory Boardno datano datano data
Robert Graham
Member of Scientific Advisory Boardno datano datano data
Jane Bell
Independent Non-Executive Director1.6yrsUS$139.29k0.027%
$ 153.6k
Richard Gilbert
Member of Scientific Advisory Boardno datano datano data
Stephen Graves
Member of Scientific Advisory Boardno datano datano data
Philip Krause
Non Executive Director2yrsUS$138.33k0.034%
$ 192.3k

5.8yrs

Average Tenure

71yo

Average Age

Experienced Board: MSB's board of directors are considered experienced (5.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.